4D Molecular Therapeutics (NASDAQ:FDMT) shares surged over 60% premarket after the company reported positive interim data for its eye disease drug, 4D-150. Data consists of 24-week results from a randomized…
Hiraman/E+ via Getty Images Pharming Group N.V. (NASDAQ:PHAR) said total revenues are expected to increase by 19% to approximately $245 million for 2023. “We seek to significantly expand the leniolisib…
ssuaphoto/iStock via Getty Images Gold prices were on track for a second straight weekly gain helped by safe-haven demand amid escalating tensions in the Middle East, while investors also digested…
hernan4429/iStock via Getty Images Gold prices (XAUUSD:CUR ) ticked up on Friday as the U.S. dollar retreated from a 10-month high, although bullion was set for a second monthly drop…